Flow cytometric analysis of Notch1 and Jagged1 expression in normal blood cells and leukemia cells
- Authors:
- Eriko Kanamori
- Mai Itoh
- Naoko Tojo
- Takatoshi Koyama
- Nobuo Nara
- Shuji Tohda
View Affiliations
Affiliations: Department of Clinical Laboratory, Tokyo Medical and Dental University, Tokyo, Japan, Department of Laboratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan, Laboratory Molecular Genetics of Hematology, Tokyo Medical and Dental University, Tokyo, Japan
- Published online on: July 4, 2012 https://doi.org/10.3892/etm.2012.633
-
Pages:
397-400
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Notch1 and its ligand Jagged1 are proteins with important roles in the growth of leukemia cells. Although the detection of Notch1 protein in acute lymphoblastic leukemia cells using immunoblot analysis has been previously reported, the expression patterns of Notch1 and Jagged1 detected by flow cytometry (FCM) in normal blood cells and various leukemia cells have not been well-characterised. In the present study, we examined the expression patterns of Notch1 and Jagged1 in 10 normal blood samples, 8 bone marrow samples, 11 leukemia/lymphoma cell lines and leukemia cells from 22 patients with acute myeloid leukemia (AML), mature T-cell neoplasms or B-cell chronic lymphocytic leukemia (B-CLL) using FCM. The results showed that Notch1 expression is relatively strong in monocytes and granulocytes but weak in lymphocytes. The expression of Notch1 is stronger in bone marrow cells than in the equivalent cells in blood. All the cell lines examined strongly expressed Notch1, and eight cell lines expressed Jagged1. In leukemia cells from patients, four AML samples expressed Notch1 and/or Jagged1. However, three samples expressed neither Notch1 and/or Jagged1 and none of the mature T-cell neoplasm samples expressed either protein. However, all B-CLL samples expressed high levels of both Notch1 and Jagged1. We found that the expression of Notch1 and Jagged1 is detected in various hematological malignancies by FCM. The examination of these proteins is likely to be useful in the characterisation of diseases and individual cases. Examination of these proteins may also be useful in the selection of patients most likely to benefit from novel molecular-targeted therapies using Notch inhibitors in the future.
View References
|
1.
|
Suzuki T and Chiba S: Notch signaling in
hematopoietic stem cells. Int J Hematol. 82:285–294. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Leong KG and Karsan A: Recent insights
into the role of Notch signaling in tumorigenesis. Blood.
107:2223–2233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Weng AP, Ferrando AA, Lee W, Morris JP IV,
Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT and Aster
JC: Activating mutations of NOTCH1 in human T cell acute
lymphoblastic leukemia. Science. 306:269–271. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Tohda S and Nara N: Expression of Notch1
and Jagged1 proteins in acute myeloid leukemia cells. Leuk
Lymphoma. 42:467–472. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Tohda S, Murata-Ohsawa M, Sakano S and
Nara N: Notch ligands, Delta-1 and Delta-4 suppress the
self-renewal capacity and long-term growth of two myeloblastic
leukemia cell lines. Int J Oncol. 22:1073–1079. 2003.PubMed/NCBI
|
|
6.
|
Tohda S, Kogoshi H, Murakami N, Sakano S
and Nara N: Diverse effects of the Notch ligands Jagged1 and Delta1
on the growth and differentiation of primary acute myeloblastic
leukemia cells. Exp Hematol. 33:558–563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Lanotte M, Martin-Thouvenin V, Najman S,
Balerini P, Valensi F and Berger R: NB4, a maturation inducible
cell line with t(15;17) marker isolated from a human acute
promyelocytic leukemia (M3). Blood. 77:1080–1086. 1991.PubMed/NCBI
|
|
8.
|
Ohishi K, Varnum-Finney B, Flowers D,
Anasetti C, Myerson D and Bernstein ID: Monocytes express high
amounts of Notch and undergo cytokine specific apoptosis following
interaction with the Notch ligand, Delta-1. Blood. 95:2847–2854.
2000.PubMed/NCBI
|
|
9.
|
Radke AL, Reynolds LE, Melo RC, Dvorak AM,
Weller PF and Spencer LA: Mature human eosinophils express
functional Notch ligands mediating eosinophil autocrine regulation.
Blood. 113:3092–3101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Nwabo Kamdje AH, Mosna F, Bifari F, Lisi
V, Bassi G, Malpeli G, Ricciardi M, Perbellini O, Scupoli MT,
Pizzolo G and Krampera M: Notch-3 and Notch-4 signaling rescue from
apoptosis human B-ALL cells in contact with human bone
marrow-derived mesenchymal stromal cells. Blood. 118:380–389.
2011.PubMed/NCBI
|
